Medpace Holdings, Inc.
MEDPDiagnostics & Research
$652.01−3.77%As of Oct 30vs prior close
- Market cap
- $18.2B
- P/E (TTM)
- 35.6×
- P/E (FY1)
- 35.5×
- From 52W high
- −5.87%
- EPS (LTM)
- $18.02
- Revenue (LTM)
- $2.8B
- Net margin
- 18.24%
- Dividend yield
- 0.00%
Nomior Score
65
Steady ProfileTop 16% of the scored universe
Growth58
Quality80
Value52
Momentum52
Resilience56
Growth
+22.03%revenue a year over 9 fiscal years
YE16 $421.6MLTM $2.8B
Connections
Revenue to profitQ3 YE26
19% of revenue became net profit, up 2 pts on a year.
Who owns it
2funds, 4 tracked portfolios